ganetespib Report issue

Small molecule Experimental
AACT ChEMBL DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O
  • InChIKey: RVAQIUULWULRNW-UHFFFAOYSA-N
  • Mol. Mass: 364.41
  • ALogP: 3.25
  • ChEMBL Molecule:
    ganetespib  
More Chemistry

Pharmacology

Alternative names

ganetespib | sta9090 | sta 9090 | sta-9090

Organizations (26)

Research & Development (26)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (34)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (34)


 

Breast Neoplasms (Phase 2)

Breast Neoplasms, Male (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 1/Phase 2)

Carcinoma, Squamous Cell (Phase 1)

Colonic Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

Hamartoma (Phase 2)

Hemangiosarcoma (Phase 2)

Leukemia, Lymphoid (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Myeloid, Chronic-Phase (Phase 1)

Lung Neoplasms (Phase 1)

Melanoma (Phase 2)

Mesothelioma (Phase 1/Phase 2)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 1)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 2)

Nerve Sheath Neoplasms (Phase 1/Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Prostatic Neoplasms (Phase 2)

Rectal Neoplasms (Phase 2)

Sarcoma (Phase 1/Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Triple Negative Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 39
  • # of Trial Organizations: 26

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue